A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA-Reference-Cited by-同舟云学术

A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA

Published:2020-05 Issue:5 Volume:27 Page:560-570.e10
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Inoyama Daigo,Awasthi Divya,Capodagli Glenn C.,Tsotetsi Kholiswa,Sukheja Paridhi,Zimmerman Matthew,Li Shao-Gang,Jadhav Ravindra,Russo Riccardo,Wang Xin,Grady Courtney,Richmann Todd,Shrestha Riju,Li Liping,Ahn Yong-Mo,Ho Liang Hsin Pin,Mina Marizel,Park Steven,Perlin David S.,Connell Nancy,Dartois Véronique,Alland David,Neiditch Matthew B.,Kumar Pradeep,Freundlich Joel S.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference73 articles.

1. Identification of KasA as the cellular target of an anti-tubercular scaffold;Abrahams;Nat. Commun.,2016

2. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

3. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis;Almeida;Antimicrob. Agents Chemother.,2009

4. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis;Andries;Science,2005

5. InhA, a gene encoding a target for isoniazid and ethionamide in M. tuberculosis;Banerjee;Science,1994

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Mycobacterium tuberculosis Cell Wall: An Alluring Drug Target for Developing Newer Anti‐TB Drugs—A Perspective;Chemical Biology & Drug Design;2024-09

2. Synthesis, Molecular Docking, Molecular Dynamic Simulation Studies, and Antitubercular Activity Evaluation of Substituted Benzimidazole Derivatives;Advances in Pharmacological and Pharmaceutical Sciences;2024-03-28

3. The use of Mycobacterium tuberculosis H37Ra-infected immunocompetent mice as an in vivo model of persisters;Tuberculosis;2024-03

4. Mycobacterium tuberculosis: Pathogenesis and therapeutic targets;MedComm;2023-09-04

5. Synthesis, molecular docking, molecular dynamic simulation studies, and anti-tubercular activity evaluation of substituted benzimidazole derivatives;2023-07-13